Ex-CEO charged in New York, becomes 1st drug executive indicted in opioid crisis
Ex-CEO charged in New York, becomes 1st drug executive indicted in opioid crisis
Kemberly Richardson reports on the criminal case against a drug co. CEO stemming from opioids.
Updated 2 hours ago
NEW YORK CITY (WABC) -- One of the nation's largest distributors of opioids has entered into a non-prosecution consent decree with the US Attorney's office for the Southern District of New York, which accused the company, Rochester Drug Cooperative (RDC), of failing to properly report thousands of suspicious orders of oxycodone, fentanyl and other controlled substances.
At the same time, the company's former chief executive, Lawrence Doud, has been placed under arrest by federal drug agents. Doud is the first pharmaceutical executive associated with the nation's opioid crisis to face a criminal charge of diverting drugs for an illegitimate purpose.
The indictment unsealed Tuesday alleges Doud ordered subordinates to ignore red flags about certain pharmacy customers to maximize company revenues and his own pay, which more than doubled between 2012 and 2016 as the company's sales of drugs like oxycodone and fentanyl skyrocketed.
more...
https://abc7ny.com/5266275/?ex_cid=TA_WABC_FB&utm_campaign=trueAnthem%3A+Trending+Content&utm_content=5cbf920e0cef930001bd339b&utm_medium=trueAnthem&utm_source=facebook&fbclid=IwAR062wM9xttdskWaGImI9PBJ5qUrQQ8coXf1Si91D3Fjrog-2NjscYOjb38